136 related articles for article (PubMed ID: 38363947)
1. Identify novel inflammation-related prognostic signature in pancreatic cancer patients.
Sun Y; Zhang X; Zhu H
Medicine (Baltimore); 2024 Feb; 103(7):e36932. PubMed ID: 38363947
[TBL] [Abstract][Full Text] [Related]
2. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
5. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer.
Wang D; Zhang Y; Wang X; Zhang L; Xu S
Front Genet; 2023; 14():1022265. PubMed ID: 36741321
[No Abstract] [Full Text] [Related]
7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
8. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
9. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
[TBL] [Abstract][Full Text] [Related]
11. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
12. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
13. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
14. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
15. Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer.
Chen Y; Xu R; Ruze R; Yang J; Wang H; Song J; You L; Wang C; Zhao Y
Cancer Cell Int; 2021 Jun; 21(1):291. PubMed ID: 34090418
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA.
Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W
Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900
[TBL] [Abstract][Full Text] [Related]
20. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]